Articles liés à EFdA (Islatravir): An Outstanding Anti-HIV Modified...

EFdA (Islatravir): An Outstanding Anti-HIV Modified Nucleoside: From Conceptualization to Present-Day Clinical Findings - Couverture souple

Ohrui, Hiroshi

 
9798892481762: EFdA (Islatravir): An Outstanding Anti-HIV Modified Nucleoside: From Conceptualization to Present-Day Clinical Findings
Couverture souple
ISBN 13 : 9798892481762
Editeur : BAYSHOP (Generis Publishing), 2026

Synopsis

EFdA(4’-C-ethynyl-2-fluoro-2’-deoxyadenosine), named Islatravir by Merck, is a very excellent anti-HIV modified nucleoside. The story of its development, especially the basis of its design, advances in its synthetic methods, amazing clinical results and unexpected clinical results, and further, the possibility of EFdA as the clinical medicine, is described.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Éditeur
BAYSHOP (Generis Publishing)
Date d'édition
2026
Langue
anglais
ISBN 13 
9798892481762
Reliure
Broché
Nombre de pages
67
Coordonnées du fabricant
Printed by Amazon on behalf of the author
https://www.amazon.fr/hz/contact-us

c/o Amazon Media EU S.à.r.l., 38 Avenue John F. Kennedy
Luxembourg
L-1855
Luxembourg